archive-com.com » COM » A » AGENDIA.COM

Total: 235

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Contact Us | Agendia
    am Select A physician A patient A scientist A health care provider From diagnostic industry From pharmaceutical industry A potential investor A potential sponsor Other Salutation Select Dr Prof Mr Mrs Miss First Name Last Name Title Select MD Ph D MD Ph D Prof Other Related to Product Select Breast Colon Other Request Select Requesting a Brochure Seeking a Physician Billing Questions Follow up Call Specimen Shipping Kits Other Description Below Please enter any other requests in the comments section Phone Email Organization Country Select Afghanistan Albania Algeria American Samoa Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo Democratic Republic of the Congo Republic of the Costa Rica Côte d Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Greenland Grenada Guam Guatemala Guinea Guinea Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Northern Mariana Islands Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone

    Original URL path: http://www.agendia.com/contact-us/ (2016-05-01)
    Open archived version from archive

  • A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study | Agendia
    de Vijver S C Linn January 31 2013 The 70 gene signature MammaPrint has been developed on retrospective series of breast cancer patients to predict the risk of breast cancer distant metastases The microarRAy prognoSTics in breast cancER RASTER study was the first study designed to prospectively evaluate the performance of the 70 gene signature which result was available for 427 patients cT1 3N0M0 Adjuvant systemic treatment decisions were based on the Dutch CBO 2004 guidelines the 70 gene signature and doctors and patients preferences Five year distant recurrence free interval DRFI probabilities were compared between subgroups based on the 70 gene signature and Adjuvant Online AOL 10 year survival probability 90 was defined as high risk Median follow up was 61 6 months Fifteen percent 33 219 of the 70 gene signature low risk patients received adjuvant chemotherapy ACT versus 81 169 208 of the 70 gene signature high risk patients The 5 year DRFI probabilities for 70 gene signature low risk n 219 and high risk n 208 patients were 97 0 and 91 7 The 5 year DRFI probabilities for AOL low risk n 132 and high risk n 295 patients were 96 7 and 93 4 For 70 gene signature low risk AOL high risk patients n 124 of whom 76 n 94 had not received ACT 5 year DRFI was 98 4 In the AOL high risk group 32 94 295 less patients would be eligible to receive ACT if the 70 gene signature was used In this prospective community based observational study the 5 year DRFI probabilities confirmed the additional prognostic value of the 70 gene signature to clinicopathological risk estimations such as AOL Omission of adjuvant chemotherapy as judged appropriate by doctors and patients and instigated by a low risk 70 gene signature

    Original URL path: http://www.agendia.com/a-prospective-evaluation-of-a-breast-cancer-prognosis-signature-in-the-observational-raster-study/ (2016-05-01)
    Open archived version from archive

  • Frequently Asked Questions | Agendia
    by looking at cell surface characteristics while molecular subtyping looks deeper at the functional level to see which genes are driving the tumor s behavior Combined with MammaPrint BluePrint will determine if your breast cancer is Luminal type A or B Basal type or HER2 type These findings are important when deciding which treatment is most appropriate for your specific tumor 7 Why should I use MammaPrint and BluePrint together MammaPrint and BluePrint provide you and your doctor deeper insight into tumor pathways uncovering your hidden tumor biology By combining risk of recurrence with molecular subtyping you get a clearer picture of how your breast cancer is functioning leading to more informed treatment decision making MammaPrint is the first FDA cleared breast cancer recurrence assay and is the only breast cancer recurrence assay backed by peer reviewed prospective outcome data 1 BluePrint molecular subtyping is the most widely available molecular subtyping assay that helps identify your potential level of responsiveness to chemotherapy more accurately than IHC FISH with better correlation to long term clinical treatment outcomes 10 8 Will my insurance cover the cost of the test Agendia is in network with Medicare and many large national and regional health plans covering over 200 million lives in the United States Agendia will bill your insurance company directly throughout the US Based on your specific benefit level the insurance company may choose to pay a portion or all of the cost of the tests run by Agendia You may be responsible for any co insurance co pay or deductible per your health insurance plan terms Please call us and our dedicated patient advocates will work with you and your insurance to find out your specific coverage details Agendia s Patient Advocates can be reached at 888 363 7868 or by email at billing agendia com 9 What if I don t have insurance or my health plan won t cover the test Agendia is a compassionate company offering a wide range of financial assistance programs such as Interest free payment plans Uninsured Underinsured patient assistance Indigent patient assistance For more information or to speak with a Patient Advocate Representative about your specific situation call us at 888 363 7868 or email at billing agendia com 10 How long does it take to get results On average results are provided within 10 business days What is genomic testing Genomic tests look at your specific tumor s genes to help find out what s driving its growth Using gene expression testing to help design a tailored treatment plan is called personalized medicine These are not the same as genetic tests that determine your inherited risk or hereditary predisposition for cancer Your physician will assess many factors prior to determining your treatment plan including the size of the tumor lymph node involvement and the hormone receptor status of your cancer These factors along with your tumor s genomic profile can help you and your physician make the most informed treatment decisions for your specific

    Original URL path: http://www.agendia.com/patient/breast/faqs/ (2016-05-01)
    Open archived version from archive

  • Insurance Coverage | Agendia
    you with an estimate of your financial responsibility based on your specific benefit levels Please call 888 363 7868 and one of our Patient Advocate Representatives will gladly assist you Q What are my payment options if I have a balance due A If payment is required after your insurance company has determined their coverage Agendia will work on your behalf to ensure that the insurance company has processed the claim at the highest benefit level to minimize any out of pocket expense After a full review an invoice will be issued for any difference in coverage If you are interested in arranging an interest free payment plan please contact us and one of our Patient Advocates can assist you with this Q What if I get a bill from Agendia for more than I expected A Please contact us and one of our Patient Advocates will work to resolve the discrepancy in an acceptable and timely manner They can be reached at 888 363 7868 Q My insurance company sent me something that looks like a bill for this test Should I pay it A Your insurance company may send you one or more Explanation of Benefits EOB statements related to our test s This is not a bill from Agendia Agendia can submit an appeal s on your behalf during the claim review process and each appeal submitted will generate an EOB from your insurance company You do not have any financial obligation for the test unless you receive an invoice from Agendia Agendia is a compassionate company offering a wide range of financial assistance programs based on individual financial status Agendia offers the following programs to meet your financial needs Interest free payment plans Underinsured patient assistance Uninsured patient assistance Indigent patient assistance For more information or

    Original URL path: http://www.agendia.com/patient/breast/insurance-coverage/ (2016-05-01)
    Open archived version from archive

  • Privacy Policy | Agendia
    Account is also protected with certain user credentials i e your User ID as described in the Terms of Service You are responsible for taking all reasonable steps to ensure that no unauthorized person has access to your Client Account or User ID It is your sole responsibility to authorize monitor and control access to and use of your User ID Your information is processed and stored on controlled servers with restricted access Unfortunately we cannot ensure or warrant the security of any information you transmit to our Website and you do so at your own risk Further while Agendia uses commercially reasonable effort to ensure the integrity and security of its network and systems Agendia cannot guarantee that such security measures will prevent third party hackers from illegally obtaining access to Your Information Agendia does not warrant or represent that Your Information will be protected against loss misuse or alteration by third parties Therefore Agendia disclaims any warranties or representations relating to maintenance or non disclosure of any private information including your Personal Information 4 Information Access Updates and Choice You may choose to provide personal information to Agendia by completing the Client Account registration form sending us an e mail or otherwise contacting us In the registration form you may have an opportunity to elect to receive certain communications from us Agendia e mail correspondence will include instructions on how to update certain Personal Information and how to unsubscribe from our e mails and postal mail correspondence Please follow the instructions in the e mails to notify Agendia of changes to your name e mail address and preference information Agendia will take reasonable steps such as confirmation e mails to verify your identity before granting access to your Personal Information If you choose to unsubscribe from our e mail and or postal mail services you will no longer receive this correspondence However Agendia may retain your information for a period of time to resolve disputes troubleshoot problems or for other valid business or legal reasons 5 Third Party Information You agree that you have provided notice to and obtained consent from any third party individuals whose Personal Information you supply to us including with regard to a the purposes for which such third party s Personal Information has been collected b the intended recipients or categories of recipients of the third party s Personal Information c which of the third party s information is obligatory and which information if any is voluntary and d how the third party can access and if necessary rectify the information held about them 6 Linked Third Party Websites The Site may contain links to external websites This Privacy Statement does not apply to the privacy practices of these third party external sites Agendia does not maintain these sites and is not responsible for the privacy practices of sites that it does not operate Please refer to the specific privacy statements or policies posted on those sites AGENDIA DISCLAIMS ALL RESPONSIBILITY OR LIABILITY FOR THE ACTIONS OF PRIVACY PRACTICES OF OR INFORMATION CONTAINED ON OR COLLECTED VIA SUCH LINKED SITES 7 Use by Children The Site is directed toward adults If you are under the age of 13 you must obtain the authorization of a responsible adult parent legal custodian or teacher before using or accessing our Site We will not knowingly collect or use any Personal Information from any children under the age of 13 If we become aware that we have collected any Personal Information from children under 13 we will promptly remove such information from our databases 8 Protected Health Information The Web Portal is used for the storage and sharing of Protected Health Information between Agendia and physicians and their authorized representatives Protected Health Information is used by Agendia and or its service providers in accordance with the Health Information Portability and Accountability Act HIPAA and applicable federal and state laws governing patient privacy Protected Health Information available on or through the Web Portal will only be used or disclosed for the provision of testing services payment administration of records treatment and other authorized purposes provided in any related Terms of Use or General Terms and Conditions of the Web Portal We may use and disclose Protected Health Information to evaluate and process any requests for coverage and claims for benefits you may make or in connection with other health related benefits or services that may be of interest to you A more detailed notice of Agendia s Privacy Policy for Protected Health Information may be found in Agendia s Privacy Policy for Protected Health Information below 9 Governing Law Our Site is controlled and operated by Agendia By choosing to visit our Site or otherwise electronically provide information to Agendia you agree that any dispute over privacy or the terms contained in this Privacy Statement will be governed by the laws of the State of California and the United States of America If you are accessing our Site from any location with regulations or laws governing the collection use or disclosure of personal data which differ from California or United States laws or regulations please note that through your continued use of our Site which is governed by the laws of the State of California and the United States of America and this Privacy Statement you are transferring personal information in the United States of America and you consent to that transfer and to the collection and processing of such information in the United States You also expressly consent to the adjudication of any disputes arising in connection with our Site in the federal and state courts of Orange County in the State of California You also agree to attempt to mediate any such disputes before an action is filed in a federal or state court Questions If you have questions about the Agendia Privacy Statement please contact us at customercare agendia com Privacy Policy Notice for Protected Health Information the Notice Effective date of this Notice October

    Original URL path: http://www.agendia.com/privacy-policy/ (2016-05-01)
    Open archived version from archive

  • Terms & Service | Agendia
    Content that contains any viruses Trojan horses worms time bombs cancelbots or other disabling devices or other harmful component intended to or that may damage detrimentally interfere with surreptitiously intercept or expropriate any system software data or information to post content that you do not have the right to disclose under contractual confidentiality obligations or fiduciary duties to solicit personal information from anyone under 18 or to publicly pose information that poses or create a privacy or security risk to any person In addition as a condition to accessing the Site you agree not to a reproduce duplicate copy sell resell or exploit any portion of the Site other than as expressly allowed under these Terms of Service b use Agendia s name trademarks server or other materials in connection with or to transmit any unsolicited communications or emails c use any high volume automated or electronic means to access the Site including without limitation robots spiders scripts or web scraping tools d frame the Site place pop up windows over its pages or otherwise affect the display of its page or e interfere with or disrupt the Site or servers or networks connected to the Site or disobey any requirements procedures policies or regulations of networks connected to the Site 4 3 Interactions with Other Users You are solely responsible for your interactions with other Users of the Site Agendia reserves the right but has no obligation to monitor disputes between you and other users of the Site IF YOU HAVE A DISPUTE WITH ANY OTHER USER OF THE SITE YOU RELEASE AGENDIA AND ITS AGENTS OFFICERS PRINCIPALS AND EMPLOYEES FROM ANY AND ALL CLAIMS DEMANDS AND DAMAGES ACTUAL AND CONSEQUENTIAL OF EVERY KIND AND NATURE KNOWN AND UNKNOWN SUSPECTED AND UNSUSPECTED DISCLOSED AND UNDISCLOSED ARISING OUT OF OR IN ANY WAY CONNECTED WITH SUCH DISPUTE 5 Content 5 1 User Content The Site may allow you to participate in blogs message boards online forums and other functionality and if any of the foregoing functionalities are enabled on the Site you may have the opportunity to create submit post display transmit perform publish distribute or broadcast content and materials post to Agendia and or to or via the Site including without limitation text writings photographs graphics comments suggestions or personally identifiable information or other material collectively User Content Agendia does not claim any ownership rights in the User Content You understand that all User Content available on the Site is the sole responsibility of the person from whom such User Content originated without Agendia incurring any third party obligations or liability arising of its exercise of the rights thereto granted herein by you Agendia retains the right to pre screen police control edit or monitor the User Content available on the Site and to remove any User Content at any time for any reason including but not limited to upon receipt of claims or allegations from third parties or authorities relating to such User Content or for no reason at all However you acknowledge and agree that Agendia has no responsibility to and may or may not do the foregoing As such Agendia does not warrant or otherwise guarantee the accuracy integrity or quality of any User Content It is your responsibility to evaluate the User Content and any other information content opinions and advice available on the Site AGENDIA ASSUMES NO RESPONSIBILITY AND MAKES NO REPRESENTATIONS WARRANTIES RECOMMENDATIONS ENDORSEMENTS OR APPROVALS WITH REGARD TO USER CONTENT Under no circumstances will Agendia be liable for any loss or damage arising out of or relating in any way to any User Content including but not limited to a any errors or omissions in any User Content b any loss or damage of any kind incurred as a result of the use of or reliance on any User Content c use or misuse by any Site user or third party of any User Content that you post in connection with your use of the Site such as on the Forum as described further below or d your exposure to offensive indecent or otherwise objectionable User Content via the Site 5 2 Your Content You agree that you are solely responsible for any User Content that you provide to or otherwise distribute or publish on the Site such User Content Your Content By providing Your Content you i grant to Agendia a perpetual irrevocable worldwide royalty free fully paid up transferable sublicensable license to access use reproduce display store publish transmit modify and distribute Your Content in connection with the operation of the Site including the right to sublicense any of the foregoing rights to others ii represent and warrant that you have the right to grant the foregoing license and iii represent and warrant that Your Content is in compliance with these Terms of Service and all applicable laws rules and regulations and does not violate the rights of any third party By providing Your Content you also consent to the use of Your Content by other Users of this Site for its intended purpose s which include without limitation rights with respect to Content granted to you and other Users who separately agree to these Terms of Service under the terms of Section 6 Intellectual Property Rights 6 INTELLECTUAL PROPERTY RIGHTS Except for Client Account information and User Content including Your Content all other content on the Site including but not limited to information documents materials code images text layouts arrangements displays trademarks illustrations audio and video clips HTML and other mark up languages and all scripts collectively Content is owned by or licensed to Agendia and in many cases is protected by intellectual property rights under U S foreign and international law Agendia grants you a non exclusive non transferable non sublicensable limited right to access use and display the Content pursuant to these Terms of Service and solely in connection with your use of the Site or the Web Services All rights not expressly granted by these Terms

    Original URL path: http://www.agendia.com/terms-service/ (2016-05-01)
    Open archived version from archive

  • References | Agendia
    et al Nature Jan 2002 415 530 536 McGee et al EMBO Reports Oct 2006 doi 10 1038 sj embor 7400839 Knauer et al Breast Cancer Res Treat Mar 2010 120 3 655 661 US FDA 510K Clearance K101454 Delahaye L et al Personalized Medicine 2013 10 3 801 811 Glück S et al Breast Cancer Res Treat June 2013 139 3 759 767 Cristofanilli M et al Cancer Res 2012 72 24 Suppl Abstract nr P3 05 01 Krijgsman O et al Breast Cancer Res Treat Aug 2012 133 37 47 Tian S et al Biomarker Insights Nov 2010 5 129 138 Whitworth P et al Annals of Surg Onc Oct 2014 10 326 7 Roepman P et al Clin Cancer Res Nov 2009 15 7003 7011 Oyama T et al Breast Cancer Apr 2007 14 182 8 Allred DC The Oncologist Nov 2008 13 11 1134 1136 Viale G et al Annals of Oncology Apr 2014 25 4 816 823 Maak M et al Annals of Surgery Jun 2013 257 6 1053 1058 Benson AB 3rd et al J Clin Oncol 2004 22 3408 3419 Salazar R et al JCO Jan 2011 29 1 17 24 Tabernero J

    Original URL path: http://www.agendia.com/references/ (2016-05-01)
    Open archived version from archive

  • Agendia Resources | Agendia
    am Select A patient A physician A health care provider A scientist Other Request Select Requesting Specimen Shipment Kits Requesting a Follow up Call Requesting a Brochure Billing Questions Other Description Below Product Related To Select Breast Colon Other Organization Country Select Afghanistan Albania Algeria American Samoa Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo Democratic Republic of the Congo Republic of the Costa Rica Côte d Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Greenland Grenada Guam Guatemala Guinea Guinea Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Northern Mariana Islands Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Sudan South Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu

    Original URL path: http://www.agendia.com/agendia-resources/ (2016-05-01)
    Open archived version from archive



  •